OGI Bio is delighted to announce the appointment of Andrew Murphy to its Board of Directors. With extensive experience in scaling businesses and strategic leadership, Andrew brings invaluable expertise to support our next phase of growth.
Andrew has a proven track record of driving success across the technology and life sciences sectors, making him a perfect fit for OGI Bio as we expand our global reach and continue innovating in microbial culturing automation.
“We are thrilled to welcome Andrew to the board,” said Dr. Alex McVey, CEO of OGI Bio. “His insights and guidance will be instrumental as we continue to build on our strong foundation and accelerate our impact in the biotechnology space.”
Andrew’s appointment reflects OGI Bio’s commitment to assembling a leadership team that will drive long-term success and sustainable growth. We look forward to achieving new milestones with his support.